Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy

Author： Bazhin Alexandr Shevchenko Ivan Umansky Viktor Werner Jens Karakhanova Svetlana

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.63, Iss.1, 2014-01, pp. : 59-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders: findings from a pilot study

By Qiu Ying Yun Mark Xu Ming Wang Yi Yun Sheng

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 657-665

Springer Publishing Company

Access to resources Recommend Favorite

Genes Associated with Epithelial-Mesenchymal Transition: Possible Therapeutic Targets in Ductal Pancreatic Adenocarcinoma?

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 5, 2011-06 ,pp. : 448-454

Bentham Science Publishers

Access to resources Recommend Favorite

Pancreatic Resection for M1 Pancreatic Ductal Adenocarcinoma

By Shrikhande Shailesh Kleeff Jörg

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 118-127

Springer Publishing Company

Access to resources Recommend Favorite

Mouse Models of Metastatic Pancreatic Adenocarcinoma

By Xie Keping Wang Bailiang Shi Qian Abbruzzese James L Xiong Qinghua Le Xiangdong

International Journal of Gastrointestinal Cancer, Vol. 29, Iss. 1, 2001-02 ,pp. : 25-36

Humana Press, Inc

Access to resources Recommend Favorite

Appendicular Metastasis From Pancreatic Adenocarcinoma

By Filik Levent Ozdal-Kuran Sedef Cicek Bahattin Zengin Neslihan Ozyilkan Ozgur Sahin Burhan

International Journal of Gastrointestinal Cancer, Vol. 34, Iss. 1, 2004-02 ,pp. : 55-58

Humana Press, Inc

Access to resources Recommend Favorite